This is the authors' abstract. We don't add key points for this paper.
Gastric cancers are heterogeneous. There are important differences between gastric and junctional tumors and a focus on evidence based on true gastric cancers is important to guide treatment decision and the design of innovative strategies. We present key evidence shaping the current use of radiotherapy, discuss technical radiotherapy considerations that are important to consider in multidisciplinary decision-making, and highlight selected research strategies including radiotherapeutic advances, theranostic approaches and key ongoing clinical trials to watch that will shape the role of radiotherapy in gastric cancers for the future.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mesci et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: